Case Type: Mergers & Acquisitions

We are investigating First Financial Corporation (NasdaqGS: THFF) (“First Financial”) regarding First Financial’s acquisition of HopFed Bancorp, Inc. (“HopFed”), where in exchange for all outstanding shares of HopFed capital stock, First Financial expects to offer Hopfed 0.444 shares of First Financial common stock, or $21.00 in cash for each share of HopFed common stock owned.

We are investigating SunCoke Energy Inc. (NYSE:SXC) regarding the company’s purchase of SunCoke Energy Partners, L.P. Under the terms of the proposed transaction, SunCoke Energy Partners stockholders will receive 1.40 shares of SunCoke Energy, Inc. for each share of SunCoke Energy Partners common stock owned.

We are investigating Bridgepoint Education, Inc. (NYSE: BPI) regarding Bridgepoint’s acquisition of Fullstack Academy, Inc., where in exchange for all outstanding shares of Fullstack capital stock, Bridgepoint expects to pay $17.5 million in cash and issue 2,500,000 shares of Bridgepoint common stock.

We are investigating CenturyLink, Inc. (NYSE: CTL) regarding the NOL Rights Plan between CenturyLink and Computershare Trust Company, N.A., where each share of CenturyLink common stock will carry with it one preferred share purchase right.

We are investigating GTx, Inc. (NasdaqCM: GTXI) (“GTx”) regarding the merger agreement between GTx and Oncternal Therapeutics, Inc., where GTx stockholders will own approximately 25% of the combined company.

We are investigating HFF, Inc. (NYSE: HF) (“HFF”) regarding the sale of HFF to Jones Lang LaSalle Incorporated (“JLL”), where HFF shareholders will receive $24.63 in cash and 0.1505 shares of JLL for each share of HFF they own.

We are investigating the Board of Directors of Uniti Financial Corporation (OTC: UIFC) related to the sale of the company to BayCom Corp. Under the terms of the proposed transaction, each share of Uniti common stock will be converted into the right to receive (i) $2.30 in cash and (ii) 0.07234 shares of BayCom common … Read more

We are investigating the Board of Directors of AmpliPhi Biosciences Corporation (NYSE: APHB) related to the sale of the Company to C3J Therapeutics, Inc. Under the terms of the proposed transaction, AmpliPhi stockholders will own 30% of AmpliPhi common stock upon completion of the transaction.

We are investigating the sale of Nightstar Therapeutics plc (NasdaqGS: NITE) to Biogen Switzerland Holdings GmhH. Under the terms of the proposed transaction, Nightstar stockholders will receive $25.50 in cash for each Nightstar share they own.

We are investigating Coty, Inc. (NYSE: COTY) (“Coty”) regarding the tender offer Coty received from Cottage Holdco B.V. (“Cottage”), where Cottage will acquire up to 150 million shares of the Company’s Class A common stock at a price of $11.65 per share in cash.